Skip to content

Pulsed Electromagnetic Field Stimulation and Charcot Foot Ulcer

Pulsed Electromagnetic Field Stimulation and Charcot Foot Ulcer: a Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06527131
Enrollment
34
Registered
2024-07-30
Start date
2024-07-31
Completion date
2024-11-30
Last updated
2024-07-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Charcot Foot Ulcer

Brief summary

thirty-four patients with charcot foot ulcer will be included, their ages will be ranged from 50 to 70 years old and randomly distributed into two equal groups : study group includes 17 patients who will recieve pulsed electromagnetic field and electrical stimulation three days per week for three months . control group includes 17 patients who will recieve electrical stimulation , standard wound care and medical treatment

Interventions

PEMF is regarded as an efficient physical therapy method that has been utilized clinically to treat a variety of orthopedic conditions, including delayed union and nonunion of fractures. According to studies, PEMF has been authorized for its biological effects, which include the mineralization of bone matrix, osteogenic differentiation of mesenchymal stem cells, and osteoblast proliferation

Electrical stimulation consider a safe and cost-effective method for pain management. It has no side effects and few contraindication in addition to no drug interaction . According to studies ,electrical stimulation decreases pain through reducing central transmission of pain signals because of nociceptive inhibition at the presynaptic level in the dorsal horn.

DRUGVancomycin

medical antibiotics

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
50 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* age ranges between 50 and 70 years old male and female patients all patients with charcot foot ulcer

Exclusion criteria

* presence of malignancy hypotensive patients pregnancy immunological and rheumatological disorders

Design outcomes

Primary

MeasureTime frameDescription
rate of bone healingBaseline and three monthsasses rate of bone healing through plain x-ray after six weeks then after twelve weeks from initiation of treatment

Secondary

MeasureTime frameDescription
ulcrer healingbaseline and three monthsasses wound surface area through wound surface area Tracing pre treatment ,after six weeks and after twelve weeks from initiation of treatment

Countries

Egypt

Contacts

Primary ContactNorhan Eltayeb, MSc candidate
1400534@st.pt.cu.edu.eg01288053957
Backup ContactNessrien AbdelRashid, assistant professor
nessrien.afify@pt.cu.edu.eg01143872680

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026